US Patent Issued to ModernaTX on Oct. 6 for "Mutant influenza B/Victoria lineage virus hemagglutinin proteins" (New Jersey, Massachusetts Inventors)

ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,752,001, issued on Oct. 6, was assigned to ModernaTX Inc. (Cambridge, Mass.).

"Mutant influenza B/Victoria lineage virus hemagglutinin proteins" was invented by Raffael Nachbagauer (Rahway, N.J.), Farbod Mahmoudinobar (Rahway, N.J.) and Elif Nihal Korkmaz (Brookline, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Some aspects of the disclosure relate to vaccines (e.g., RNA vaccines (e.g., mRNA vaccines)) for seasonal influenza viruses as well as methods of using the vaccines. Also described are combination vaccines (e.g., RNA vaccines (e.g., mRNA vaccines)) for seasonal influenza viruses and other respiratory viruses (e.g., respiratory syncytial vi...